These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1353020)

  • 1. Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells.
    Spoelstra EC; Westerhoff HV; Dekker H; Lankelma J
    Eur J Biochem; 1992 Jul; 207(2):567-79. PubMed ID: 1353020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
    Spoelstra EC; Westerhoff HV; Pinedo HM; Dekker H; Lankelma J
    Eur J Biochem; 1994 Apr; 221(1):363-73. PubMed ID: 7909520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of daunorubicin transport in Ehrlich ascites tumor cells with different expression of P-glycoprotein.
    Nielsen D; Maare C; Skovsgaard T
    Biochem Pharmacol; 1994 Jun; 47(12):2125-35. PubMed ID: 7913318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative importance of passive and P-glycoprotein mediated anthracycline efflux from multidrug-resistant cells.
    Wielinga PR; Westerhoff HV; Lankelma J
    Eur J Biochem; 2000 Feb; 267(3):649-57. PubMed ID: 10651800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin.
    Versantvoort CH; Broxterman HJ; Feller N; Dekker H; Kuiper CM; Lankelma J
    Int J Cancer; 1992 Apr; 50(6):906-11. PubMed ID: 1348241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport.
    Spoelstra EC; Dekker H; Schuurhuis GJ; Broxterman HJ; Lankelma J
    Biochem Pharmacol; 1991 Feb; 41(3):349-59. PubMed ID: 1671638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daunorubicin efflux against a concentration gradient in non-P-glycoprotein multidrug-resistant lung-cancer cells.
    Mülder HS; Lankelma J; Dekker H; Broxterman HJ; Pinedo HM
    Int J Cancer; 1994 Oct; 59(2):275-81. PubMed ID: 7927929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity.
    Mülder HS; Dekker H; Pinedo HM; Lankelma J
    Biochem Pharmacol; 1995 Sep; 50(7):967-74. PubMed ID: 7575681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saturable P-glycoprotein kinetics assayed by fluorescence studies of drug efflux from suspended human KB8-5 cells.
    Ghauharali RI; Westerhoff HV; Dekker H; Lankelma J
    Biochim Biophys Acta; 1996 Jan; 1278(2):213-22. PubMed ID: 8593279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influx of daunorubicin in multidrug resistant Ehrlich ascites tumour cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil.
    Nielsen D; Maare C; Skovsgaard T
    Biochem Pharmacol; 1995 Aug; 50(4):443-50. PubMed ID: 7646548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative P-glycoprotein mediated daunorubicin transport into DNA-loaded plasma membrane vesicles.
    Guiral M; Viratelle O; Westerhoff HV; Lankelma J
    FEBS Lett; 1994 Jun; 346(2-3):141-5. PubMed ID: 7912204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A plasma membrane 'vacuum cleaner' for daunorubicin in non-P-glycoprotein multidrug-resistant SW-1573 human non-small cell lung carcinoma cells. A study using fluorescence resonance energy transfer.
    Mülder HS; van Grondelle R; Westerhoff HV; Lankelma J
    Eur J Biochem; 1993 Dec; 218(3):871-82. PubMed ID: 8281939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.
    Versantvoort CH; Broxterman HJ; Pinedo HM; de Vries EG; Feller N; Kuiper CM; Lankelma J
    Cancer Res; 1992 Jan; 52(1):17-23. PubMed ID: 1309222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
    Mankhetkorn S; Garnier-Suillerot A
    Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
    Mankhetkorn S; Dubru F; Hesschenbrouck J; Fiallo M; Garnier-Suillerot A
    Mol Pharmacol; 1996 Mar; 49(3):532-9. PubMed ID: 8643093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia.
    Horio M; Chin KV; Currier SJ; Goldenberg S; Williams C; Pastan I; Gottesman MM; Handler J
    J Biol Chem; 1989 Sep; 264(25):14880-4. PubMed ID: 2570070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein.
    Roepe PD
    Biochemistry; 1992 Dec; 31(50):12555-64. PubMed ID: 1361758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
    Vergote J; Moretti JL; de Vries EG; Garnier-Suillerot A
    Eur J Biochem; 1998 Feb; 252(1):140-6. PubMed ID: 9523723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efflux of anthracyclines in multidrug-resistant cell lines.
    Coley HM; Twentyman PR; Workman P
    Biochem Pharmacol; 1993 Oct; 46(8):1317-26. PubMed ID: 7902089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles.
    Sinicrope FA; Dudeja PK; Bissonnette BM; Safa AR; Brasitus TA
    J Biol Chem; 1992 Dec; 267(35):24995-5002. PubMed ID: 1360981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.